Drug Testing
Drug Testing
Info: Types of Drug Testing
To understand the principles behind
drug testing technology, some knowledge is required about
the way in which the body deals with chemical compounds
such as drugs. Irrespective of the method of intake, all
drugs, pharmaceutical and otherwise, undergo a series of
bio-chemical reactions in the body. These reactions
release the active compound and then gradually degrade the
drug into slightly different structures. These structures,
also called metabolites, are then excreted from the body
in a variety of ways.
What do labs test
for?
The first thing to know about drug
testing is what the standard test looks for. What is being
tested for varies greatly based on testing company,
expense, expectations, federal requirements etc. Following
is a description of what to expect from the standard drug
testing.
Marijuana, cocaine (including
crack), opiates (including heroin), methamphetamine,
phencyclidine (PCP or angel dust), and ecstasy (MDMA).
These drugs were identified as "illegal drugs"
in the Presidents Executive Order 12564 and are the five
drugs mandated for drug testing by the federal government
The NIDA 5 Federal government
guidelines (by NIDA-The National Institute on Drug Abuse
and SAMHSA-The Substance Abuse and Mental Health Services
Administration) require that companies which use
commercial class drivers licenses for employees must have
a drug testing system in place. Among other things, this
required drug testing program must test for 5 specific
categories of drugs (sometimes referred to as the "NIDA
5"). Because of this federal requirement, most drug
testing companies offer a basic drug test which checks for
drugs in these 5 common categories. Click on the substance
name for a description of the laboratory method for
detecting the substance.
- Cannabinoids (marijuana, hash)
- Cocaine (cocaine, crack,
benzoylecognine)
- Amphetamines (amphetamines,
methamphetamines, speed)
- Opiates (heroin, opium, codeine,
morphine)
- Phencyclidine (PCP)
Expanded Drug Testing
Most drug testing companies also
offer an expanded test which includes a few additional
drugs in the testing process. Most do not add all of these
in their expanded test, but choose a different combination
of 3 or 4 to add :
- Barbituates (Phenobarbital,
Secobarbitol, Butabital)
- Hydrocodone (Lortab, Vicodin)
- Methaqualone (Qualuudes)
- Benzodiazepines (Valium, Librium,
Serax, Rohypnol)
- Methadone
- Propoxyphene (Darvon compounds)
- Ethanol (Alcohol)
Urine
Drug Testing
Urine drug testing is the most
common type. Urine is the specimen of choice since it
contains the most metabolites of a drug taken. Urine is
the main excretory route for drugs and their metabolites.
The following is a summary of the analytical methods used
by laboratories to detect the presence of drugs or their
metabolites in the urine:
Immunoassays
These drug testing procedures are
most commonly used to screen samples. In the event that
drugs or their metabolites are detected, then the sample
is normally tested again using an even more sensitive test
such as Gas Chromatography and Mass Spectometry.
Immunoassays work on the principle of antigen-antibody
interaction. Antibodies are chosen which will bind
selectively to drugs or their metabolites. The binding is
then detected using either enzymes, radioisotopes or
fluorescent compounds.
EMIT (Enzyme Multiplied Immunoassay
Technique) is manufactured by Syva Laboratories. It uses
an enzyme as the detection mechanism. It is the cheapest,
simplest to perform and the most widely used of the
immunoassays. The EMIT is commonly used by employers as an
initial drug testing step. The EMIT is the most commonly
used test for pre-employment screenings despite having a
4-34% "false positive" rate.
RIA (Radio Immunoassay) is
manufactured by Roche Diagnostics. It is similar to EMIT
but uses a radioactive isotope such as iodine instead of
an enzyme. However, because it involves using radioactive
substances, it is less popular than EMIT. This is a highly
sensitive form of drug testing mainly used by the
military. Mistakes come from poor calibration. The
manufacturer states that "a positive test result
should be confirmed."
FPI (Fluorescence Polarization Immunoassay) is
manufactured by Abbott Laboratories. Fluorescent compounds
mark the selective binding of antibodies to drugs and
their metabolites. It is a highly sensitive and highly
specific type of drug testing.
Chromatography
TLC (Thin Layer Chromatography)
This drug testing procedure involves the addition of a
solvent to the sample causing the drugs and their
metabolites to travel up a porous strip leaving color
spots behind. As each different substance travels a
specific distance, the strip can then be compared with
known standards. This type of drug testing gives no
quantitive information, it merely indicates the presence
of drugs or their metabolites. Furthermore, it relies on
the subjective judgment of a technician and requires
considerable skill and training. False positives result
from misinterpretations. It is not widely used.
GC/MS (Gas Chromatography/Mass Spectometry)
This is the most precise type of drug testing for
identifying and quantifying drugs or their metabolites in
the urine. The GC/MS is routinely used as a confirmation
test following a positive result on an Immunoassay. It
involves a two step process, whereby Gas Chromatography
separates the sample into its constituent parts and Mass
Spectometry identifies the exact molecular structure of
the compounds. The combination of Gas Chromatography and
Mass Spectometry is considered to be the definitive method
of establishing the presence of drugs or their metabolites
in the urine. However, the equipment necessary to perform
it is extremely expensive and this is reflected in the
price for drug testing each sample. Occasionally problems
do arise with poor calibration of the equipment. Mistakes
also commonly happen if the machine is not thoroughly
cleaned - samples can be contaminated by small traces from
the previous urine drug testing sample. Temperature,
pressure, and storage time of samples must be rigidly
controlled.
Although urine is most commonly
tested, occasionally laboratories use one of the following
methods to detect the presence of drugs or their
metabolites:
Hair Follicle
Drug Testing
The technology behind the hair drug
testing was pioneered by Psychemedics Corporation in 1987.
Psychemedics Corporation is the world's leading laboratory
for the drug testing of hair for the presence of drugs.
Its client list includes over 2,200 corporations (over 10%
of the Fortune 500), which use hair drug testing as part
of their drug-free workplace programs. In addition, five
of the country's largest police departments as well as
schools and Federal Reserve Banks rely on Psychemedics'
hair testing.
When drug metabolites are circulated in the blood, they
enter the scalp's blood vessels and are filtered through
the hair. These metabolites remain in the hair and provide
a permanent record of drug use. With a one-inch hair
sample containing about 50 strands, labs can detect the
use of drugs within the past three months.
A standard screen covers a period of
approximately 90 days. The hair drug testing sample is cut
as close to the scalp as possible and the most recent 3.9
centimeters (approximately 1 1/2 inches) are tested. The
hair sample is cut as close to the scalp as possible and
the most recent 3.9 centimeters (approximately 1 1/2
inches) are tested. Assuming the sample is taken from the
head, the amount of hair needed is a snip about the
thickness of a shoelace tip.
Hair can be collected from several
locations on the head and combined to obtain the required
amount of hair. If necessary, body hair can be used as an
alternative to head hair. If you have very short hair,
labs can take a drug testing sample from any part of the
body.
Psychemedics Corporation (Amex: PMD)
announced today it has received 510(K) clearance from the
Food and Drug Administration (FDA) for its drug testing
detection of marijuana use through human hair analysis.
Psychemedics has now received FDA clearance for the five
drug panel routinely used in drug testing.
Psychemedics' marijuana drug testing
system employs radioimmunoassay for the qualitative
screening and mass spectrometry for quantification of
carboxy -- THC in hair for the purpose of identifying
marijuana use.
The hair is clipped and then
dissolved in a series of solvents. Psychemedics' patented
technology that detects drugs in hair using
radioimmunoassay. RIAH® (Radioimmunoassay of Hair)
measures the drug molecules permanently entrapped in hair
which were incorporated following ingestion. The
laboratory then analyzes the liquified sample using Gas
Chromatography and Mass Spectometry. This makes it a
highly sensitive test, yet the considerable cost and
prolonged process means that it isn't often used. It also
usually requires a confirmation test using urine.
People with dark hair are 10-50
times more likely to test positive for drug use. Hair drug
testing is widely used in the casino industry. Companies
such as Blockbuster Video and Subway perform hair follicle
drug testing on all employees. Pschemedics markets their
PDT-90 hair drug testing collection kit to parents to be a
deterrent to drug use and to tell whether a child has used
drugs in the previous several months. The PDT-90 is
available in some pharmacies and drugstores.
Perspiration
Drug Testing (Sweat
Patch)
PharmaChem has produced a drug
testing patch which is worn on the skin for a period of
time. The patch contains a mechanism which is able to
detect the presence of drugs or their metabolites as they
are excreted in the individual's perspiration. The drug
testing patch is used mainly to monitor individuals who
are on parole or probation. The use of the sweat patch to
detect drug use was recently approved by the FDA. The
patch is used mainly to monitor people on parole or
probation. The drug testing patch is tamper proof and each
one has a serial number.
Saliva Drug
Testing (aka
Swab Drug Testing)
The FDA has recently given Epitope,
Inc approval to begin manufacturing saliva drug testing.
In a study using RIA (Radioimmunoassay) test, cannabinoids
were detected in saliva 4 to 10 hours after subjects
smoked a single marijuana joint. Epitope has recently
developed a test which detects drugs or their metabolites
in saliva. However, this sort of drug testing is limited
to detecting very recent drug use. In one study, saliva
testing was only able to detect cannabinoids 4-10 hours
after the subjects had been smoking. It is likely that
this drug testing will be confined to detecting current
intoxication only.
"Saliva drug testing has been
touted as a "fitness for duty" test, as its
window of detection begins as soon as a drug is ingested.
Saliva drug testing will reveal only current or very
recent (within the past twelve hours) marijuana use, but
will detect use of cocaine, opiates, methamphetamine and
Ecstasy over the past two to three days (urine will detect
these drugs for three or four days after use). Saliva is
typically experienced as cleaner and less intrusive than
urine, and there are currently no known methods for
defeating saliva drug testing. Saliva drug testing testing
is useful for pre-employment, random, post-accident and
for-cause testing. Both lab-based and on-site systems are
available; the on-site system offers results ten minutes
after taking the saliva sample. Saliva tests compare
favorably in price to urine testing. "
In oral fluid, drugs will be
detected within minutes after use.
In urine drug testing, drugs will
remain undetected in the first 4-8 hours.
- Marijuana 12-24 hrs
- Opiates 24-48 hrs
- Amphetamine 24-48 hrs
- Methamphetamine 24-48 hrs
- Cocaine 12-24 hrs
Saliva drug testing for drugs of
abuse can provide both qualitative and quantitative
information on the drug status of an individual undergoing
testing. Self-administration by the oral, intranasal, and
smoking routes may result in contamination of the oral
cavity. Generally, the level of drug detected in the oral
cavity is related to the relative acidity of the saliva
and there are established chemical relationships that can
be used to estimate the blood level once the saliva level
and its relative acidity are known. Since there is a high
correlation of saliva drug concentrations with plasma, the
application of saliva drug testing for drugs of abuse may
be successfully utilized in a variety of applications,
including the following:
- Detection - employment, health
exams, insurance
- Treatment - diagnosis,
compliance, abstinence
- Forensics - reasonable suspicion
testing, DUI, evidence investigation
LifePoint, Inc. - IMPACT System
The use of saliva as the specimen of choice adds
significant advantages to the LifePoint IMPACT Test System
when used for drug testing for drugs of abuse. Saliva drug
testing offers the ability to obtain "current
status" or "blood-equivalent" information
for drugs of abuse, compared to urine drug testing
results, which indicate prior drug use by an individual
over 2-5 days. This is a very significant advantage since
only a blood test done with sophisticated laboratory
equipment can provide similar information. This advantage
is extremely relevant in the initial market segments being
targeted.
- Saliva is the only easily
obtainable specimen in which the measured level of
many analytes correlates with their corresponding
levels in blood.
- Using saliva as a specimen
provides for non-invasive and observable specimen
collection compared to blood (invasive) and urine (not
easily observable) as specimen types.
- Saliva is a "natural
fit" as a specimen of choice for on-site testing.
Previous attempts to use saliva as a
test specimen have been limited to the use of absorption
as a collection methodology. Absorption has significant
limitations, including a slow collection time and
potential loss of an analyte due to absorption in the
collection pad. Additionally, collection for transport to
lab does not allow for quantitative drug testing because
the originally collected volume of saliva is not known.
Current on-site drug testing is often limited to a single
test because multiple tests require large amounts of
saliva.
There are two initial drug testing
panels to choose from. The first panel performs the
National Institute on Drug Abuse (NIDA) 5 drugs
(marijuana, cocaine, PCP, amphetamines/methamphetamines,
and opiates). The second panel performs the NIDA-5 drugs
plus alcohol.
We will rapidly expand the drug
testing menu. Future drug tests include Benzodiazepines,
Barbiturates, Ecstasy, and TCA (tri-cyclic
antidepressants). These will be available in a wide
variety of panel formats to meet market requirements.
The drug testing instrument allows
you to obtain a near-simultaneous saliva sample to send to
a laboratory for GC/MS confirmation.
The drug testing system has all the
necessary attributes to become "evidentiary"
(i.e., instrument read, outstanding quality of result,
etc.), and meets the Frye and Daubert standards for court
admissibility. However, since the system is just coming to
market, it has not yet been tested in a court case.
Saliva collection AND drug testing
with the IMPACT Test System take less than 5 minutes.
LifePoint will be submitting our
alcohol test for DOT approval as an evidentiary test. The
DOT has not yet approved any on-site or saliva products
for drug testing. However, SAMHSA guidelines are being
reviewed to include saliva and on-site tests as acceptable
by DOT.
LifePoint has initially targeted the
law enforcement, industrial workplace and emergency room
markets.
AVITAR INCORPORATED - ORALscreen
ORALscreenTM is the first rapid on-site oral fluid
screening device for drugs of abuse testing. ORALscreen
uses Avitar's proprietary polyurethane and oral fluid
technology to detect up to four classes of drugs of abuse
(opiates, marijuana, cocaine, and methamphetamine -
including MDMA/Ecstasy). It takes only fifteen minutes to
obtain accurate drug testing results.
Orasure Technologies, Inc. -
Intercept
The InterceptT oral fluid drug testing was introduced in
February as a collaborative effort of LabOne, STC
Technologies, Inc., and Epitope, Inc. (NASDAQ: EPTO). All
three drug testing companies play pivotal roles in the
marketing of this new lab service. STC, the leader in oral
fluid immunoassay technology, provides reagents as well as
marketing support. Epitope produces the InterceptT
collection device and provides sales support for the
criminal justice and public health markets. Laboratory
drug testing, result report, workplace sales, and account
management support are assumed by LabOne.
In partnership with several leading lab partners, OraSure
Technologies markets Intercept®, the first
laboratory-based oral fluid drug test. The Intercept®
test serves the workplace and criminal justice drug
testing markets.
Blood Drug
Testing
Although expensive and intrusive,
blood drug testing is the most accurate confirmation of
drug use. Since blood drug testing accurately detects the
presence of the drug or its metabolites at the time of
testing, the results from this type of test are the best
indication of current intoxication. Blood drug testing for
the use of drugs is primarily used in accident
investigations and for health insurance or life insurance
exams. Marijuana can be detected up to six hours after
consumption by testing blood; after that, the metabolite
concentration falls rapidly, and cannabinoids are not
detectable in the blood after 22 hours.
Fingernail
Analysis
Fingernails, like hair, are made of
the protein keratin. Results of a fingernail sample will
represent drug use that is approximately 4-5 months from
the time of ingestion. Fingernails can be clipped, or, if
length does not allow, can be shaved in a safe and
pain-free drug testing sample collection.
Eye Drug Testing
The eye testing is made by PMI
Incorporation, based in Maryland. The test consists of a
pair of goggles hooked up to a computer, and it uses light
to measure pupil size and reflex to light. The readings
are compared against a previously established baseline,
and if the pupil is dilated or reacts more slowly then the
test shows positive. The eye scan can only determine if
the person is currently impaired and can not determine if
impairment is caused by drugs, alcohol, and lack of sleep
or other causes. Generally, a person that tests positive
on an eye drug testing scan will be subjected to a
subsequent urinalysis to determine what toxin is causing
the impairment. Two other similar tests, the EM/2 and FIT
tests measure the rapid eye movement of the pupil. The
drug testing manufactures claim a 97% accuracy rate.
Problems with eye or nerve abnormalities raise questions
about drug testing accuracy.
|